Although these approaches were suitable to address the role of TP53 for early aspects of tumour formation, the requirement of persistent TP53 inactivation in already established tumours has only recently been addressed and confirmed (Martins et al, 2006; Ventura et al, 2007; Xue et al, 2007). This evidence concerns the gene TP53 and neoplasm.